An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions

This study, called FINEROD, is designed to understand more about a new medicine called finerenone. This medicine has recently become available for doctors to prescribe to people who have both long-term kidney problems (chronic kidney disease, or CKD) and a common type of diabetes called type 2 diabetes. When you have type 2 diabetes, your body either doesn't make enough of a hormone called insulin or doesn't use it properly. This can lead to high blood sugar levels, which can damage your kidneys over time.

Finerenone works by blocking certain proteins in the body, which might help to protect the kidneys, heart, and blood vessels from further damage. Because it's a new treatment, doctors and researchers want to gather more information about how it's being used in everyday medical practice. They want to see how safe it is and how well it works for people under normal conditions, rather than in a strict research setting.

To do this, the study isn’t asking people to take new medicines or have extra doctor visits. Instead, researchers will look at existing health information that doctors and hospitals already collect. This includes details like a person's age, gender, kidney health, any heart problems, and other medicines they might be taking. By studying these records, they hope to get a clearer picture of who is taking finerenone and what their experiences are like.